Analysis of Chinese Medicine in the Treatment of Rheumatoid Arthritis

Abstract

Objective: to explore the prescription of Chinese patent medicine for the treatment of rheumatoid arthritis. Methods: the Chinese patent medicines for the treatment of rheumatoid arthritis in the 2015 edition of the Chinese Pharmacopoeia and the Ministry of Standards were collected, and the composition of the drug, the frequency of drug use, and precautions are analyzed. The rheumatoid joints are searched in conjunction with the Chinese website. The literature on Chinese patent medicines of inflammation is summarized in its clinical application status and characteristics. Results: among the proprietary Chinese medicines for treating rheumatoid arthritis, the top five traditional Chinese medicines with the highest frequency of use are Angelicae sinensis radix (28, 4.7%), Glycyrrhizae radix et rhizoma (27, 4.6%), Aconiti kusnezoffii radix (26, 4.4%), Aconiti radix (25, 4.2%), Cinnamomi ramulus (24, 4.1%). Conclusion: the composition of proprietary Chinese medicines for rheumatoid arthritis is mainly based on rheumatoid arthritis, tonic medicine, blood stasis and phlegm-removing drugs, and is consistent with the pathogenesis of rheumatoid arthritis considered by Chinese medicine.